{
    "nct_id": "NCT03535727",
    "official_title": "A Phase I/II Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan (GAX-CI) in Combination in Metastatic Pancreatic Cancer",
    "inclusion_criteria": "* Have histologically or cytologically confirmed untreated metastatic pancreatic adenocarcinoma.\n* Patients with the presence of at least one measurable lesion.\n* Male or non-pregnant and non-lactating female of age >18 years.\n* Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1.\n* Patients must have adequate organ and marrow function defined by study-specified laboratory tests.\n* Must use acceptable form of birth control while on study.\n* Ability to understand and willingness to sign a written informed consent document.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 76 Years",
    "exclusion_criteria": "* Patients who will be considered for surgery are ineligible.\n* Patient who have had any prior chemotherapy within 5 years of enrollment.\n* Patient who have had radiotherapy for pancreatic cancer.\n* Age â‰¥ 76 years\n* Patient who is receiving or have received any other investigational agents within 28 days prior to Day 1 of treatment in this study.\n* Patient who has undergone major surgery, other than diagnostic surgery within 28 days prior to Day 1 of treatment in this study.\n* Patient who has known brain metastases.\n* Patient with history of hypersensitivity or allergic reactions attributed to compounds of similar chemical or biologic composition to gemcitabine, nab-paclitaxel, capecitabine, cisplatin, or irinotecan.\n* Patient with uncontrolled intercurrent illness including, but not limited to, uncontrolled infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.\n* Patient who has serious medical risk factors involving any of the major organ systems.\n* Patient who has known history of infection with HIV, hepatitis B, or hepatitis C.\n* Pregnant or breast feeding.\n* Patient is unwilling or unable to comply with study procedures\n* Patient with clinically significant wound.",
    "miscellaneous_criteria": ""
}